Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as key therapies for the treatment of obesity and type 2 diabetes, with several agents demonstrating cardiovascular benefits 7,8,9,10,11,12
However, this is a relatively rare side effect and often mild
The safety concern is different
3.1.1 Relationship between amino acid metabolism and ferroptosis The system Xc , a cystine/glutamate antiporter located on the cell membrane, consists of the light chain SLC7A11 and heavy chain SLC3A2, linked via disulfide bonds
Shed GLP-1 is a telehealth platform offering GLP-1 prescription, delivery, and lifestyle coaching